Fundación Hospital Alcorcón   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Alcorcón Spain (1997)

Organization Overview

First Clinical Trial
2009
NCT01015248
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Fundación Hospitalaria de Alcorcón de Madrid | Fundación Hospital de Alcorcón

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 4)

Head and Neck Neoplasms (Phase 2)

Lymphoma (Phase 2)

Lymphoma, B-Cell, Marginal Zone (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Mantle-Cell (Phase 2)

Vomiting (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 8